 | • レポートコード：MRC2012A7859 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、受容体型チロシンプロテインキナーゼ標的薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。受容体型チロシンプロテインキナーゼ標的薬の種類別市場規模（ジマレイン酸アファチニブ、ダコミチニブ、ネラチニブ、ノイカルディン、その他）、用途別市場規模（腫瘍、心臓血管、中枢神経系、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Aslan Pharmaceuticals Pte Ltd、Puma Biotechnology Inc、Hanmi Pharmaceuticals Co Ltd、Boehringer Ingelheim GmbH、Pfizer Inc、GamaMabs Pharma SA、XuanZhu Pharma Co Ltd、Minerva Neurosciences Inc、Jiangsu Kanion Pharmaceutical Co Ltd、Shanghai Fosun Pharmaceutical (Group) Co Ltd、Zensun (Shanghai) Sci & Tech Co Ltd、 ・地域別グローバル市場分析 2015年-2020年 ・受容体型チロシンプロテインキナーゼ標的薬の北米市場（アメリカ、カナダ、メキシコ） ・受容体型チロシンプロテインキナーゼ標的薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・受容体型チロシンプロテインキナーゼ標的薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・受容体型チロシンプロテインキナーゼ標的薬の南米市場（ブラジル、アルゼンチン） ・受容体型チロシンプロテインキナーゼ標的薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ジマレイン酸アファチニブ、ダコミチニブ、ネラチニブ、ノイカルディン、その他 ・用途別分析：腫瘍、心臓血管、中枢神経系、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Receptor Tyrosine Protein Kinase Targeted Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Receptor Tyrosine Protein Kinase Targeted Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Receptor Tyrosine Protein Kinase Targeted Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Receptor Tyrosine Protein Kinase Targeted Drugs market has been segmented into
Afatinib Dimaleate
Dacomitinib
Neratinib
Neucardin
Others
By Application, Receptor Tyrosine Protein Kinase Targeted Drugs has been segmented into:
Oncology
Cardiovascular
Central Nervous System
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Receptor Tyrosine Protein Kinase Targeted Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Receptor Tyrosine Protein Kinase Targeted Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Receptor Tyrosine Protein Kinase Targeted Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Receptor Tyrosine Protein Kinase Targeted Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Receptor Tyrosine Protein Kinase Targeted Drugs Market Share Analysis
Receptor Tyrosine Protein Kinase Targeted Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Receptor Tyrosine Protein Kinase Targeted Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Receptor Tyrosine Protein Kinase Targeted Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Receptor Tyrosine Protein Kinase Targeted Drugs are:
Aslan Pharmaceuticals Pte Ltd
Puma Biotechnology Inc
Hanmi Pharmaceuticals Co Ltd
Boehringer Ingelheim GmbH
Pfizer Inc
GamaMabs Pharma SA
XuanZhu Pharma Co Ltd
Minerva Neurosciences Inc
Jiangsu Kanion Pharmaceutical Co Ltd
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Zensun (Shanghai) Sci & Tech Co Ltd
Among other players domestic and global, Receptor Tyrosine Protein Kinase Targeted Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Receptor Tyrosine Protein Kinase Targeted Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Receptor Tyrosine Protein Kinase Targeted Drugs, with price, sales, revenue and global market share of Receptor Tyrosine Protein Kinase Targeted Drugs in 2018 and 2019.
Chapter 3, the Receptor Tyrosine Protein Kinase Targeted Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Receptor Tyrosine Protein Kinase Targeted Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Receptor Tyrosine Protein Kinase Targeted Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Receptor Tyrosine Protein Kinase Targeted Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Receptor Tyrosine Protein Kinase Targeted Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Afatinib Dimaleate
1.2.3 Dacomitinib
1.2.4 Neratinib
1.2.5 Neucardin
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Others
1.4 Overview of Global Receptor Tyrosine Protein Kinase Targeted Drugs Market
1.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Aslan Pharmaceuticals Pte Ltd
2.1.1 Aslan Pharmaceuticals Pte Ltd Details
2.1.2 Aslan Pharmaceuticals Pte Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Aslan Pharmaceuticals Pte Ltd SWOT Analysis
2.1.4 Aslan Pharmaceuticals Pte Ltd Product and Services
2.1.5 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Puma Biotechnology Inc
2.2.1 Puma Biotechnology Inc Details
2.2.2 Puma Biotechnology Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Puma Biotechnology Inc SWOT Analysis
2.2.4 Puma Biotechnology Inc Product and Services
2.2.5 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hanmi Pharmaceuticals Co Ltd
2.3.1 Hanmi Pharmaceuticals Co Ltd Details
2.3.2 Hanmi Pharmaceuticals Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hanmi Pharmaceuticals Co Ltd SWOT Analysis
2.3.4 Hanmi Pharmaceuticals Co Ltd Product and Services
2.3.5 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim GmbH
2.4.1 Boehringer Ingelheim GmbH Details
2.4.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim GmbH SWOT Analysis
2.4.4 Boehringer Ingelheim GmbH Product and Services
2.4.5 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer Inc
2.5.1 Pfizer Inc Details
2.5.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer Inc SWOT Analysis
2.5.4 Pfizer Inc Product and Services
2.5.5 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GamaMabs Pharma SA
2.6.1 GamaMabs Pharma SA Details
2.6.2 GamaMabs Pharma SA Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GamaMabs Pharma SA SWOT Analysis
2.6.4 GamaMabs Pharma SA Product and Services
2.6.5 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 XuanZhu Pharma Co Ltd
2.7.1 XuanZhu Pharma Co Ltd Details
2.7.2 XuanZhu Pharma Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 XuanZhu Pharma Co Ltd SWOT Analysis
2.7.4 XuanZhu Pharma Co Ltd Product and Services
2.7.5 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Minerva Neurosciences Inc
2.8.1 Minerva Neurosciences Inc Details
2.8.2 Minerva Neurosciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Minerva Neurosciences Inc SWOT Analysis
2.8.4 Minerva Neurosciences Inc Product and Services
2.8.5 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Jiangsu Kanion Pharmaceutical Co Ltd
2.9.1 Jiangsu Kanion Pharmaceutical Co Ltd Details
2.9.2 Jiangsu Kanion Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Jiangsu Kanion Pharmaceutical Co Ltd SWOT Analysis
2.9.4 Jiangsu Kanion Pharmaceutical Co Ltd Product and Services
2.9.5 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Shanghai Fosun Pharmaceutical (Group) Co Ltd
2.10.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Details
2.10.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd SWOT Analysis
2.10.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Product and Services
2.10.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Zensun (Shanghai) Sci & Tech Co Ltd
2.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Details
2.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Zensun (Shanghai) Sci & Tech Co Ltd SWOT Analysis
2.11.4 Zensun (Shanghai) Sci & Tech Co Ltd Product and Services
2.11.5 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
4.5 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
6.3 UK Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
6.4 France Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
7.5 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2015-2020)
11 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Application
11.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2015-2020)
11.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025)
12.2.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025)
12.2.4 South America Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025)
12.3 Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share Forecast by Type (2021-2025)
12.4 Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Receptor Tyrosine Protein Kinase Targeted Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Aslan Pharmaceuticals Pte Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 9. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Aslan Pharmaceuticals Pte Ltd SWOT Analysis
Table 11. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 12. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Puma Biotechnology Inc Basic Information, Manufacturing Base and Competitors
Table 14. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 15. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Puma Biotechnology Inc SWOT Analysis
Table 17. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 18. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Hanmi Pharmaceuticals Co Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 21. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Hanmi Pharmaceuticals Co Ltd SWOT Analysis
Table 23. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 24. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 26. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 27. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Boehringer Ingelheim GmbH SWOT Analysis
Table 29. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 30. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 33. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Pfizer Inc SWOT Analysis
Table 35. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 36. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GamaMabs Pharma SA Basic Information, Manufacturing Base and Competitors
Table 38. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 39. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 40. GamaMabs Pharma SA SWOT Analysis
Table 41. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 42. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. XuanZhu Pharma Co Ltd Basic Information, Manufacturing Base and Competitors
Table 44. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 45. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 46. XuanZhu Pharma Co Ltd SWOT Analysis
Table 47. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 48. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Minerva Neurosciences Inc Basic Information, Manufacturing Base and Competitors
Table 50. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 51. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Minerva Neurosciences Inc SWOT Analysis
Table 53. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 54. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Jiangsu Kanion Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 57. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Jiangsu Kanion Pharmaceutical Co Ltd SWOT Analysis
Table 59. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 60. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Shanghai Fosun Pharmaceutical (Group) Co Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 63. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Shanghai Fosun Pharmaceutical (Group) Co Ltd SWOT Analysis
Table 65. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 66. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Zensun (Shanghai) Sci & Tech Co Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Business
Table 69. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Zensun (Shanghai) Sci & Tech Co Ltd SWOT Analysis
Table 71. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product and Services
Table 72. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 74. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Regions (2015-2020) (K Pcs)
Table 76. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Regions (2015-2020)
Table 77. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2015-2020) (K Pcs)
Table 79. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries (2015-2020)
Table 80. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2015-2020)
Table 82. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2015-2020) (K Pcs)
Table 83. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries (2015-2020)
Table 84. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Regions (2015-2020) (K Pcs)
Table 86. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2015-2020) (K Pcs)
Table 89. South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries (2015-2020)
Table 90. South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2015-2020) (K Pcs)
Table 93. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2015-2020)
Table 96. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2015-2020) (K Pcs)
Table 97. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2015-2020)
Table 98. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2015-2020) (USD Million)
Table 99. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2015-2020)
Table 100. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2015-2020) (K Pcs)
Table 101. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Application (2015-2020)
Table 102. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 103. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share Forecast by Regions (2021-2025)
Table 104. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 105. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share Forecast by Type (2021-2025)
Table 106. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application (2021-2025)
Table 107. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase Targeted Drugs Picture
Figure 2. Global Sales Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Type in 2019
Figure 3. Afatinib Dimaleate Picture
Figure 4. Dacomitinib Picture
Figure 5. Neratinib Picture
Figure 6. Neucardin Picture
Figure 7. Others Picture
Figure 8. Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application in 2018
Figure 9. Oncology Picture
Figure 10. Cardiovascular Picture
Figure 11. Central Nervous System Picture
Figure 12. Others Picture
Figure 13. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Manufacturer in 2019
Figure 34. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Regions (2015-2020)
Figure 41. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Regions in 2018
Figure 42. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
Figure 43. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
Figure 45. South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020)
Figure 47. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries (2015-2020)
Figure 49. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries in 2018
Figure 50. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries in 2018
Figure 52. United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries in 2019
Figure 58. Germany Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Regions 2019
Figure 66. China Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries in 2019
Figure 73. South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries in 2019
Figure 74. Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
受容体チロシンプロテインキナーゼ標的薬の世界市場（～2026年） Market Analysis and Insights: Global Receptor Tyrosine Protein Kinase Targeted Drugs Market The global Receptor Tyrosine Protein Kinase Targeted Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Receptor Tyrosine P…- チロシンプロテインキナーゼ受容体TYRO3の世界市場（～2026年） Market Analysis and Insights: Global Tyrosine Protein Kinase Receptor TYRO3 Market The global Tyrosine Protein Kinase Receptor TYRO3 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tyrosine Protein Kinase Receptor TYRO…
- 非受容体型チロシンプロテインキナーゼTYK2の世界市場（～2026年） Market Analysis and Insights: Global Non Receptor Tyrosine Protein Kinase TYK2 Market The global Non Receptor Tyrosine Protein Kinase TYK2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Non Receptor Tyrosine Protein K…
- 受容体チロシンプロテインキナーゼERBB4の世界市場（～2026年） Market Analysis and Insights: Global Receptor Tyrosine Protein Kinase ERBB 4 Market The global Receptor Tyrosine Protein Kinase ERBB 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Receptor Tyrosine Protein Kinase ER…
- 受容体型チロシンプロテインキナーゼERBB4の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Receptor Tyrosine Protein Kinase ERBB 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recep…